Role of oxidative stress in preeclampsia and intrauterine growth restriction

Journal of Obstetrics and Gynaecology Research

Volumn 38, Issue 4, 2012, Pages 658-664

  Mert, Ismail ^a   Oruc, Ayla Sargin ^b   Yuksel, Serdar ^b   Cakar, Esra Sukran ^b   Buyukkagnici, Umran ^b   Karaer, Abdullah ^c   Danisman, Nuri ^b  

^a HUTZEL HOSPITAL   (United States)

^b ZEKAI TAHIR BURAK WOMEN S HEALTH EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^c INONU UNIVERSITY   (Turkey)

Author keywords

Intrauterine growth restriction; Oxidative stress; Preeclampsia; Sister chromatid exchange

Indexed keywords

ANTIOXIDANT; OXIDIZING AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MICRONUCLEUS; OXIDATIVE STRESS; PERIPHERAL LYMPHOCYTE; PREECLAMPSIA; SISTER CHROMATID EXCHANGE;

ADOLESCENT; ADULT; ANTIOXIDANTS; FEMALE; FETAL GROWTH RETARDATION; HUMANS; LINEAR MODELS; MICRONUCLEI, CHROMOSOME-DEFECTIVE; OXIDATIVE STRESS; PRE-ECLAMPSIA; PREGNANCY; SISTER CHROMATID EXCHANGE;

EID: 84860859602     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2011.01771.x     Document Type: Article

References (40)

1. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365: 7785-7799.
2. Resnik R. Intrauterine growth restriction. Obstet Gynecol 2002; 99: 490-496. (Pubitemid 34188412)
3. Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006; 195: 40-49. (Pubitemid 43927490)
4. Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: Implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003; 69: 1-7. (Pubitemid 36806800)
5. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38: 1103-1111.
6. Erel O. A new automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004; 37: 112-119. (Pubitemid 38077161)
7. Tucker JD, Preston RJ. Chromosome aberrations, micronuclei, aneuploidy, sister chromatid exchange and cancer risk assessment. Mutat Res 1996; 365: 147-159. (Pubitemid 26344744)
8. Latt SA, Schreck RR. Sister chromatid exchange analysis. Am J Hum Genet 1980; 32: 297-313. (Pubitemid 11105556)
9. Perry P, Wolff S. New Giemsa method for the differential staining of sister chromatids. Nature 1974; 251: 156-158.
10. Fenech M, Moorley AA. Measurement of micronuclei in lymphocytes. Mutat Res 1985; 147: 29-36. (Pubitemid 15111220)
11. Jauniaux E, Poston L, Burton GJ. Placental-related diseases of pregnancy: Involvement of oxidative stress and implications in human evolution. Hum Reprod Update 2006; 12: 747-755. (Pubitemid 44605512)
12. Burton GJ, Yung HW, Cindrova-Davies T, Charnock-Jones DS. Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta 2009; 23: 43-48.
13. Kaur G, Mishra S, Sehgal A, Prasad R. Alterations in lipid peroxidation and antioxidant status in pregnancy with preeclampsia. Mol Cell Biochem 2008; 313: 37-44.
14. Regan CL, Levine RJ, Baird DD et al. No evidence for lipid peroxidation in severe preeclampsia. Am J Obstet Gynecol 2001; 185: 572-578. (Pubitemid 32862541)
15. Knapen MF, Peters WH, Mulder TP, Merkus HM, Jansen JB, Steegers EA. Glutathione and glutathione-related enzymes in deciduas and placenta of controls and women with preeclampsia. Placenta 1999; 20: 541-546. (Pubitemid 29391297)
16. Harma M, Harma M, Erel O. Measurement of the total antioxidant response in preeclampsia with a novel automated method. Eur J Obstet Gynecol Reprod Biol 2005; 118: 47-51. (Pubitemid 39647022)
17. Mikhail MS, Anyaegbunam A, Garfinkel D, Palan PR, Basu J, Romney SL. Preeclampsia and oxidant nutrients: Decreased plasma levels of reduced ascorbic acid, alpha-tocopherol, and beta-carotene in women with preeclampsia. Am J Obstet Gynecol 1994; 171: 150-157. (Pubitemid 24254434)
18. Karacay O, Dincel-Sepici A, Karcaaltincaba D et al. A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24-36 weeks of gestation. Diabetes Res Clin Pract 2010; 89: 231-238.
19. Llurba E, Gratacos E, Martin-Gallan P, Cabero L, Dominguez C. A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy. Free Radic Biol Med 2004; 37: 557-570. (Pubitemid 38901088)
20. Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol 2004; 122: 369-382. (Pubitemid 39506594)
21. Gupta P, Narang M, Banerjee BD, Basu S. Oxidative stress in term small for gestational age neonates born to under nourished mothers: A case control study. BMC Pediatr 2004; 4: 14-21.
22. Takagi Y, Nikaido T, Toki T et al. Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. Virchows Arch 2004; 44: 49-55. (Pubitemid 38200090)
23. Longini M, Perrone S, Kenanidis A et al. Isoprostanes in amniotic fluid: A predictive marker for fetal growth restriction in pregnancy. Free Radic Biol Med 2005; 38: 1537-1541. (Pubitemid 40703925)
24. Biri A, Bozkurt N, Turp A, Kavutcu M, Himmetoglu O, Durak I. Role of oxidative stress in intrauterine growth restriction. Gynecol Obstet Invest 2007; 64: 187-192. (Pubitemid 350099002)
25. Toy H, Camuzcuoglu H, Arioz DT, Kurt S, Celik H, Aksoy N. Serum prolidase activity and oxidative stress markers in pregnancies with intrauterine growth restricted infants. J Obstet Gynecol Res 2009; 35: 1047-1053.
26. Bainbridge SA, Roberts JM. Uric acid as a pathogenic factor in preeclampsia. Placenta 2008; 29 (Suppl A): 67-72.
27. Simic M, Jovanovic S. Antioxidation mechanisms of uric acid. J Am Chem Soc 1989; 111: 5778-5782.
28. Maples KR, Mason RP. Free radical metabolite of uric acid. J Biol Chem 1988; 263: 1709-1712. (Pubitemid 18052118)
29. Hubel CA, Kagan VE, Kisin ER, McLaughlin MK, Roberts JM. Increased ascorbate radical formation and ascorbate depletion in plasma from women with preeclampsia: Implication for oxidative stress. Free Radic Biol Med 1997; 23: 597-609. (Pubitemid 27287343)
30. Bainbridge SA, Roberts JM, von Versen-Höynck F, Koch J, Edmund L, Hubel CA. Uric acid attenuates trophoblast invasion and integration into endothelial cell monolayers. Am J Physiol Cell Physiol 2009; 297: 440-450.
31. Parks DA, Williams TK, Beckman JS. Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine:A reevaluation. Am J Physiol 1988; 254: 768-774.
32. Norppa H. Cytogenetic biomarkers. IARC Sci Publ 2004; 157: 179-205.
33. Shigenaga MK, Ames BN. Assays for 8-hydroxy-2- deoxyguanosine a biomarker of in vivo oxidative DNA damage. Free Radic Biol Med 1991; 10: 211-216. (Pubitemid 121003230)
34. Natarajan T. Chromosome aberrations: Past, present and future. Mutat Res 2002; 504: 3-16.
35. Heddle JA, Cimino MC, Hayashi M et al. Micronuclei as an index of cytogenetic damage: Past, present, and future. Environ Mol Mutagen 1991; 18: 277-291.
36. Wilson DM, Thompson LM. Molecular mechanisms of sister chromatid exchange. Mutat Res 2007; 616: 11-23.
37. Lee KH, Abe S, Yanabe Y, Matsuda I, Yoshida MC. Superoxide-dismutase activity and chromosome damage in cultured chromosome instability syndrome cells. Mutat Res 1990; 244: 251-256. (Pubitemid 20200405)
38. Norppa H, Bonassi S, Hansteen IL et al. Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutat Res 2006; 600: 37-45.
39. Calderon-Margalit R, Friedlander Y, Yanetz R et al. Preeclampsia and subsequent risk of cancer: Update from the Jerusalem Perinatal Study. Am J Obstet Gynecol 2009; 200: 63.e1-5.
40. Nechuta S, Paneth N, Velie EM. Pregnancy characteristics and maternal breast cancer risk: A review of the epidemiologic literature. Cancer Causes Control 2010; 21: 967-989.